Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Scribe Therapeutics, Inc. (SCTX) since 2026 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Scribe Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1853921.
Total stock buying since 2026: $44,690,333.
Total stock sales since 2026: $0.
Total stock option exercises since 2026: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 2,396,904 | $44,690,333 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-07 | 2,396,904 | $44,690,333 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-07-28 | Avoro Ventures Llc | Buy | 7,905 | 18.25 | 144,266 |
| 2026-07-24 | Avoro Ventures Llc | Buy | 2,383,333 | 18.66 | 44,461,077 |
| 2026-07-23 | Parrot David (Chief Financial Officer) | Buy | 2,666 | 15.00 | 39,990 |
| 2026-07-23 | Lucas Svetlana (Chief Business Officer) | Buy | 3,000 | 15.00 | 45,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of SCTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Scribe Therapeutics, Inc. (symbol SCTX, CIK number 1853921) see the Securities and Exchange Commission (SEC) website.